Skip to main content
Theralase Technologies Inc. logo

Theralase Technologies Inc. — Investor Relations & Filings

Ticker · TLT ISIN · CA88337V1004 LEI · 529900NI3Y8GLE2IBF28 TSXV Manufacturing
Filings indexed 698 across all filing types
Latest filing 2024-12-05 Regulatory Filings
Country CA Canada
Listing TSXV TLT

About Theralase Technologies Inc.

https://theralase.com/

Theralase Technologies Inc. designs, develops, manufactures, and markets patented laser technology platforms for both bio-stimulative and bio-destructive medical applications. The company operates two core divisions. The first is Cool Laser Therapy (CLT), which utilizes proprietary super-pulsed laser systems for therapeutic purposes, focusing on pain management, inflammation reduction, tissue repair, and the effective elimination of chronic knee pain. The second is Anti-Cancer Therapy (ACT), which employs patented light-activated Photo Dynamic Compounds (PDCs) combined with laser technology for destructive applications, specifically targeting the safe and effective destruction of cancer, bacteria, and viruses.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2024-12-05 English
News release - English.pdf
Regulatory Filings
2024-11-27 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2024-11-27 English
Interim MD&A - English.pdf
Regulatory Filings
2024-11-27 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed information about securities distribution, including issuer details, underwriter information, distribution dates, purchaser information, types of securities distributed, compensation related to the distribution, and directors/officers information. The form is a regulatory filing related to exempt distributions of securities, which is a compliance and disclosure document rather than a financial report or earnings announcement. It does not contain financial statements, management discussion, or audit information. The form is a regulatory compliance report filed with securities regulators to disclose exempt distributions under Canadian securities laws. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory compliance documents that do not fit other specific categories.
2024-11-22 English
News release - English.pdf
Regulatory Filings
2024-11-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.